Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

PrimaryBid.com Offer

8 Dec 2020 16:53

RNS Number : 9796H
Ideagen PLC
08 December 2020
Ā 

Ā 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF IDEAGEN PLC.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRNĀ 779021)

Ā 

8 December 2020

Ā 

Ideagen Plc

("Ideagen" or the "Company") (AIM: IDEA)

PrimaryBid.com Offer

Ideagen Plc (AIM: IDEA),Ā a leading supplier of Information Management software to highly regulated industries, is pleased to announce,Ā a conditional offer for subscription via PrimaryBid (the "PrimaryBid Offer") of new ordinary shares of 1p each in the Company ("New Ordinary Shares")Ā at an issue price of 215 pence per New Ordinary Share (the "Issue Price"). The Company is also conducting a placing of new Ordinary Shares at the Issue Price by way of an accelerated bookbuild process (the "Placing") as announced earlier today.

The PrimaryBid Offer is conditional on the new Ordinary Shares to be issued pursuant to the PrimaryBid Offer and the Placing being admitted to trading on AIM ("Admission").Ā Admission is expected to be take place at 8.00 a.m. on 14 December 2020. The PrimaryBid Offer will not be completed without the Placing also being completed.

At present, the Company has visibility over a number of potential acquisitions which the board of Ideagen (the "Board") considers to be attractive and that could enhance shareholder value for the long term. Discussions with these acquisition prospects are at differing stages of development and, whilst there can at this stage be no certainty that these acquisitions will be completed nor what the precise terms of such acquisitions could be, the Company is confident based on its track record that attractive target assets are available.

The Board intends to deploy the net proceeds of the Placing, together with its existing debt facilities, to fund this acquisition pipeline and associated costs. The Board believes that having access to readily available capital to deploy on acquisitions will enhance the Company's position in negotiating and executing upon this pipeline. The Company also continues to regularly review its financing facilities to ensure an effective and optimal capital structure, and will continue to do so as the business evolves both organically and inorganically.

Should no acquisitions be made within a reasonable period of time, the Company will set the proceeds against its existing revolving credit facility in order to reduce interest payments. In this scenario, the funds held in these accounts will be readily available to be drawn against acquisitions as and when required.

PrimaryBid Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the PrimaryBid Offer by applying exclusively through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, via the PrimaryBid.com platform, is now open to individual and institutional investors and will close at 7:30 p.m. on 8 December 2020. The PrimaryBid Offer may close early if it is oversubscribed.

The Company in consultation with PrimaryBid reserves the right to scale back any order at its discretion. The Company and PrimaryBid reserve the right to reject any application for subscription under the Offer without giving any reason for such rejection.

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid.com or the procedure for applications under the PrimaryBid Offer, visitĀ www.PrimaryBid.comĀ or call PrimaryBid.com on +44 20 3026 4750.Ā 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rankĀ pari passuĀ in all respects with the Company's existing Ordinary Shares.

Ideagen Plc

David Hornsby, Executive Chairman

Ben Dorks, Chief Executive Officer

Emma Hayes, Chief Financial Officer

Ā 

01629 699 100

PrimaryBid Limited

Fahim Chowdhury / James Deal

Ā 

0203 026 4750

finnCap Ltd (Nomad, Joint Bookrunner & Joint Broker)

Henrik Persson

James Thompson

Kate Washington (Nomad)

Alice Land (ECM)

Ā 

Ā 

020 7220 0500

Canaccord Genuity Limited (Joint Bookrunner & Joint Broker)

Simon Bridges

Richard Andrews

Ā 

Ā 

020 7523 8000

Details of the Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Offer. The Company is therefore making the Offer available exclusively through PrimaryBid.com.

The Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of aĀ prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

There is a minimum subscription of £100 per investor under the terms of the Offer which is open to existing shareholders and other investors subscribing via PrimaryBid.com.

For further details please refer to the PrimaryBid.com website atĀ www.PrimaryBid.com. The terms and conditions on which the Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt.Ā 

Ā 

Ā 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
MSCUWVNRRAUURAA
Date   Source Headline
22nd Oct 201911:26 amRNSHolding(s) in Company
17th Oct 20193:32 pmRNSDirector/PDMR Shareholding
11th Oct 20197:00 amRNSAcquisition of Optima Diagnostics Limited
7th Oct 20193:29 pmRNSNotice of AGM
4th Oct 201910:45 amRNSExercise of Options, Issue of Shares and TVR
1st Oct 20197:00 amRNSExercise of Options, Issue of Shares and TVR
25th Sep 20197:00 amRNSRedland Acquisition Update - New Contract Wins
17th Sep 20197:00 amRNSDirector Dealing and Total Voting Rights
13th Sep 201912:08 pmRNSIssue of shares under the Share Incentive Plan
3rd Sep 20198:48 amRNSHolding(s) in Company
27th Aug 20192:21 pmRNSExercise of Options and Issue of Shares
14th Aug 20194:04 pmRNSIssue of New Shares under the Share Incentive Plan
30th Jul 201912:26 pmRNSHolding(s) in Company
22nd Jul 20194:20 pmRNSIssue of New Shares under the Share Incentive Plan
17th Jul 20197:00 amRNSPreliminary Results
19th Jun 201910:24 amRNSHolding(s) in Company
10th Jun 20197:00 amRNSAcquisition of Redland Solutions Ltd
30th May 20197:00 amRNSContract Award with New Tier 1 Airline Customer
15th May 20197:00 amRNSCapital Markets Day
14th May 20197:00 amRNSTrading Statement
12th Apr 20192:43 pmRNSDirector Dealings
11th Apr 20195:06 pmRNSIssue of Shares, Director Dealings and TVR
29th Mar 20197:00 amRNSExtension to 2018 Long Term Incentive Plan awards
25th Feb 20198:00 amRNSExercise of Options and Issue of Shares
30th Jan 201910:03 amRNSExercise of Options and issue of shares
28th Jan 20194:33 pmRNSIssue of new shares under the Share Incentive Plan
22nd Jan 20197:00 amRNSUnaudited Interim Results
21st Jan 20198:46 amRNSHolding(s) in Company
15th Jan 20197:00 amRNSAppointment of Joint Broker
14th Jan 20197:00 amRNSAcquisition of Scannell Solutions Ltd
11th Dec 20183:37 pmRNSIssue of Shares, Director Dealings and TVR
5th Dec 20182:54 pmRNSHolding(s) in Company
22nd Nov 201812:12 pmRNSHolding(s) in Company
21st Nov 20187:57 amRNSHolding(s) in Company
20th Nov 201812:04 pmRNSHolding(s) in Company
19th Nov 20185:56 pmRNSHolding(s) in Company
13th Nov 20187:00 amRNSTrading Update
30th Oct 20182:28 pmRNSResult of AGM
24th Oct 20182:35 pmRNSExercise of Options and Total Voting Rights
23rd Oct 201811:19 amRNSHolding(s) in Company
23rd Oct 20187:00 amRNS2018 Long Term Incentive Plan awards
12th Oct 20183:26 pmRNSHolding(s) in Company
10th Oct 20184:18 pmRNSHolding(s) in Company
8th Oct 201812:46 pmRNSIssue of Shares and Total Voting Rights
8th Oct 20187:00 amRNSPosting of Annual Report and Notice of AGM
5th Oct 20187:00 amRNSDirectors' Dealings
3rd Oct 20184:36 pmRNSExercise of Options & Total Voting Rights
2nd Oct 20184:38 pmRNSHolding(s) in Company
2nd Oct 20184:37 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSAcquisition of Morgan Kai Group Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.